药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Quazepam
Enrofloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Flumequine
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Nemonoxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Garenoxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Technetium Tc-99m ciprofloxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quazepam
Fleroxacin
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Eravacycline
Magnesium can cause a decrease in the absorption of Eravacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Chlortetracycline
Magnesium can cause a decrease in the absorption of Chlortetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Penimepicycline
Magnesium can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Mephenesin
Magnesium can cause a decrease in the absorption of Mephenesin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Medazepam
Magnesium can cause a decrease in the absorption of Medazepam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Chlorproethazine
Magnesium can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Tetrazepam
Magnesium can cause a decrease in the absorption of Tetrazepam resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Neosaxitoxin
Magnesium can cause a decrease in the absorption of Neosaxitoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Xylazine
Magnesium can cause a decrease in the absorption of Xylazine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Pyrantel
Magnesium can cause a decrease in the absorption of Pyrantel resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Tolperisone
Magnesium can cause a decrease in the absorption of Tolperisone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Domoic Acid
Magnesium can cause a decrease in the absorption of Domoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Alcuronium
Alcuronium can cause a decrease in the absorption of Magnesium resulting in a reduced serum concentration and potentially a decrease in efficacy.
Prazepam
Gallamine
Gallamine can cause a decrease in the absorption of Magnesium resulting in a reduced serum concentration and potentially a decrease in efficacy.